SynteractHCR is a full-service, international CRO

Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the spectrum of Phase I � IV clinical studies with support services that address their specific needs.

Synteract is a full-service, international CRO

We are dedicated to bringing new treatments to market, working closely with our clients in a spirit of “Shared Work – Shared Vision.” Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the spectrum of Phase I - IV clinical studies with support services that address their specific needs. Together, we can bring tomorrow’s treatments to patients who need them, today.

Special Announcements!

thumbnailOur ICH GCP Standard Guideline booklet is here!
Is your company prepared to address new ICH GCP Guidelines to safeguard rights, safety and well-being of trial subjects? E6(R2) is the latest addendum to these quality standards. Download this free booklet for what you need to know about the updated principles, procedures and documents in clinical trials.

Latest News & Events

11/28/2017 - 11/29/2017 : Partnerships in Clinical Trials Europe Booth # 17 More...

11/20/2017: Thought leaders from Synteract, a full-service, international contract research organization (CRO), will exhibit and present at Partnerships in Clinical Trials Europe (PCT), November 28-29, Amsterdam, Netherlands. More ...

10/25/2017: CRO industry veteran John Potthoff joins Synteract Board of Directors More ...

Get in Touch

Global Headquarters:
5909 Sea Otter Place
Carlsbad, CA 92010

Phone: +1 760 268 8200
Fax: +1 760 929 1419

10/24/2017: Synteract Announces New Headquarters in Carlsbad - Learn more about the exciting changes we have seen in the past few months.
Synteract Blog

Connect With Us

11/22/2017: Our Vice President, Global Medical and Regulatory Affairs,  Dr. Martine Dehlinger-Kremer will be presenting on "The EU Clinical Trials Regulation: Are you prepared for its implementation?" on Tues., Nov. 28th at 12 noon at Partnerships In Clinical Trials. Dr. Dehlinger-Kremer will address how evolving industry needs are driving momentum towards the new regulation, the expected impact on sponsors, and steps toward preparedness. https://lnkd.in/gBQ6mDz
Synteract on LinkedIn

Follow Us

11/23/2017: RT @AHealthBlog: 10 Proven Methods That Help In Overcoming #Anxiety ➡ https://t.co/jlZmdaQetuhttps://t.co/vYQ69YNdUV
Synteract Twitter Feed

x

Contact Synteract

Tell us how to stay in touch with you:

*Required